These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 28415913

  • 1. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
    Palau J, Sancho E, Herrera M, Sánchez S, Mingot ME, Upegui RI, Rodríguez Salazar MJ, de la Cruz F, Fernández MC, González López TJ, Hernández JJ, Ríos E, López-Fernández MF, García M, Hernández JÁ, Sanz MA.
    Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
    [Abstract] [Full Text] [Related]

  • 2. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG.
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [Abstract] [Full Text] [Related]

  • 3. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT, Gonzalez CE, Sandler SG.
    Paediatr Drugs; 2005 Oct; 7(5):325-36. PubMed ID: 16220997
    [Abstract] [Full Text] [Related]

  • 4. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.
    Medeiros D, Buchanan GR.
    J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712
    [Abstract] [Full Text] [Related]

  • 5. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
    Moulis G, Germain J, Comont T, Brun N, Dingremont C, Castel B, Arista S, Sailler L, Lapeyre-Mestre M, Beyne-Rauzy O, Godeau B, Adoue D, CARMEN Investigators Group.
    Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
    [Abstract] [Full Text] [Related]

  • 6. Contemporary management of primary immune thrombocytopenia in adults.
    Lakshmanan S, Cuker A.
    J Thromb Haemost; 2012 Oct; 10(10):1988-98. PubMed ID: 22863415
    [Abstract] [Full Text] [Related]

  • 7. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, Aydin Y, Ulkü B, Aktuğlu G, Akman N.
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [Abstract] [Full Text] [Related]

  • 8. [Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)].
    Kvezereli-Kopadze MA, Kvezereli-Kopadze AN, Mtvarelidze ZG.
    Georgian Med News; 2009 Sep; (174):50-5. PubMed ID: 19801732
    [Abstract] [Full Text] [Related]

  • 9. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS, Carcao M.
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [Abstract] [Full Text] [Related]

  • 10. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS.
    Acta Haematol; 2006 Dec; 115(1-2):46-52. PubMed ID: 16424649
    [Abstract] [Full Text] [Related]

  • 11. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
    Zhou H, Fu R, Wang H, Zhou F, Li H, Zhou Z, Zhang L, Yang R.
    Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151
    [Abstract] [Full Text] [Related]

  • 12. Immune thrombocytopenic purpura in adults in the last 10 years: single-centre experience.
    Pavkovic M, Trpkovska-Terzieva S, Sotirova T, Latifi A, Cevreska L, Stojanovic A.
    Prilozi; 2012 Jan; 33(1):121-33. PubMed ID: 22952099
    [Abstract] [Full Text] [Related]

  • 13. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.
    Bennett CM, Neunert C, Grace RF, Buchanan G, Imbach P, Vesely SK, Kuhne T.
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792679
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea.
    Lee JY, Lee JH, Lee H, Kang B, Kim JW, Kim SH, Lee JO, Kim JW, Kim YJ, Lee KW, Kim JH, Choi HS, Lee JS, Bang SM.
    Thromb Res; 2017 Jul; 155():86-91. PubMed ID: 28525829
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia.
    Zhou F, Xu Y, Zhang Z, Wu X, Jin R.
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):e158-61. PubMed ID: 25493457
    [Abstract] [Full Text] [Related]

  • 18. Predictors of chronic idiopathic thrombocytopenic purpura.
    ElAlfy M, Farid S, Abdel Maksoud A.
    Pediatr Blood Cancer; 2010 Jul 01; 54(7):959-62. PubMed ID: 20405514
    [Abstract] [Full Text] [Related]

  • 19. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.
    Revel-Vilk S, Yacobovich J, Frank S, Ben-Ami T, Yechieli M, Shkalim V, Lebel A, Semo-Oz R, Tamary H.
    J Pediatr; 2013 Nov 01; 163(5):1335-9.e1-2. PubMed ID: 23891349
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.